
Novo Nordisk CEO Mike Doustdar Talks Drug Sales
Bloomberg Talks
00:00
Intro
Bloomberg opens the episode and introduces the conversation with Novo Nordisk's new CEO about company performance and product challenges.
Play episode from 00:00
Transcript


